-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Codiak BioSciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2019 to Q3 2022.
- Codiak BioSciences, Inc. Operating Income (Loss) for the quarter ending September 30, 2022 was -$21.4M, a 0.47% increase year-over-year.
- Codiak BioSciences, Inc. Operating Income (Loss) for the twelve months ending September 30, 2022 was -$53.3M, a 24.4% increase year-over-year.
- Codiak BioSciences, Inc. annual Operating Income (Loss) for 2021 was -$69.5M, a 23.5% increase from 2020.
- Codiak BioSciences, Inc. annual Operating Income (Loss) for 2020 was -$90.9M, a 13.4% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)